The current valuation score of Dare Bioscience Inc is 8.41, ranking 86 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -2.33, which is -126.09% below the recent high of 0.61 and -720.98% above the recent low of -19.13.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.